These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22929797)

  • 1. The comparative value of various employer-sponsored influenza vaccination clinics.
    Zimmerman RK; Wiringa AE; Nowalk MP; Lin CJ; Rousculp MD; Mitgang EA; Lee BY
    J Occup Environ Med; 2012 Sep; 54(9):1107-17. PubMed ID: 22929797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving influenza vaccination rates in the workplace: a randomized trial.
    Nowalk MP; Lin CJ; Toback SL; Rousculp MD; Eby C; Raymund M; Zimmerman RK
    Am J Prev Med; 2010 Mar; 38(3):237-46. PubMed ID: 20036102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.
    Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
    BMC Med; 2017 Sep; 15(1):166. PubMed ID: 28882149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economics of influenza vaccine administration timing for children.
    Lee BY; Tai JH; Bailey RR; Smith KJ; Nowalk AJ
    Am J Manag Care; 2010 Mar; 16(3):e75-e85. PubMed ID: 20205492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Program cost analysis of influenza vaccination of health care workers in Albania.
    Pallas SW; Ahmeti A; Morgan W; Preza I; Nelaj E; Ebama M; Levin A; Lafond KE; Bino S
    Vaccine; 2020 Jan; 38(2):220-227. PubMed ID: 31669063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of universal influenza vaccination in a pregnant population.
    Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
    Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
    Lee BY; Bailey RR; Wiringa AE; Afriyie A; Wateska AR; Smith KJ; Zimmerman RK
    Vaccine; 2010 Aug; 28(37):5952-9. PubMed ID: 20620168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
    Mennini FS; Bini C; Marcellusi A; Rinaldi A; Franco E
    Hum Vaccin Immunother; 2018; 14(8):1867-1873. PubMed ID: 29708843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
    Nagy L; Heikkinen T; Sackeyfio A; Pitman R
    Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
    Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
    Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Arnoux S; Weinberger C; Gessner BD
    Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
    Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
    BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
    Leung MK; You JH
    Vaccine; 2016 May; 34(22):2469-76. PubMed ID: 27079928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
    de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
    Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
    Thommes EW; Kruse M; Kohli M; Sharma R; Noorduyn SG
    Hum Vaccin Immunother; 2017 Apr; 13(4):867-876. PubMed ID: 27858509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.